4.7 Article

Novel 6β-acylaminomorphinans with analgesic activity

期刊

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
卷 69, 期 -, 页码 786-789

出版社

ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
DOI: 10.1016/j.ejmech.2013.09.031

关键词

Aminomorphinan; MOR/DOR agonist; Opioid; Analgesia; Respiratory depression; Cinnamoyl morphinamine

资金

  1. National Institute on Drug Abuse [DA034106-01, DA06241, DA02165, DA07242]
  2. National Cancer Institute [CA08748]
  3. Technology Development Fund of Memorial Sloan-Kettering Cancer Center
  4. Predoctoral Fellowship in Pharmacology from the PhRMA Foundation

向作者/读者索取更多资源

Aminomorphinans are a relatively young class of opioid drugs among which substances of high in vitro efficacy and favorable in vivo action are found. We report the synthesis and pharmacological evaluation of novel 6 beta-acylaminomorphinans. 6 beta-Morphinamine and 60-codeinamine were stereoselectively synthesized by Mitsunobu reaction. The aminomorphinans were subsequently acylated with diversely substituted cinnamic acids. In vitro binding studies on cinnamoyl morphinamines showed moderate affinity for all opiate receptors with some selectivity for mu opioid receptors, while cinnamoyl codeinamines only showed affinity for mu opioid receptors. In vivo analgesia studies showed significant analgesic activity of 6 beta-cinnamoylmorphinamine mediated by mu and delta receptors. The lead compound was found to be roughly equipotent to morphine (ED50 3.13 +/- 1.09 mg/kg) but devoid of the dangerous side-effect respiratory depression, a major issue associated with traditional opioid therapy. (C) 2013 Elsevier Masson SAS. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据